Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Rational Design of Dual-Functional Aptamers That Inhibit the Protease and Helicase Activities of HCV NS3

Identifieur interne : 002F96 ( Main/Merge ); précédent : 002F95; suivant : 002F97

Rational Design of Dual-Functional Aptamers That Inhibit the Protease and Helicase Activities of HCV NS3

Auteurs : Takuya Umehara ; Kotaro Fukuda ; Fumiko Nishikawa ; Michinori Kohara ; Tsunemi Hasegawa ; Satoshi Nishikawa [Japon]

Source :

RBID : ISTEX:70528AE6124F359D8D24EBE10DCB172BC828CCD1

Abstract

The hepatitis C virus (HCV) non-structural protein 3 (NS3) is a multifunctional enzyme with protease and helicase activities. It is essential for HCV proliferation and is therefore a target for anti-HCV drugs. Previously, we obtained RNA aptamers that inhibit either the protease or helicase activity of NS3. During the present study, these aptamers were used to create advanced dual-functional (ADD) aptamers that were potentially more effective inhibitors of NS3 activity. The structural domain of the helicase aptamer, #5Δ, was conjugated via an oligo(U) tract to the 3′-end of the dual functional aptamer NEO-III-14U or the protease aptamer G9-II. The spacer length was optimized to obtain two ADD aptamers, NEO-35-s41 and G925-s50; both were more effective inhibitors of NS3 protease/helicase activity in vitro, especially the helicase, with a four- to five-fold increase in inhibition compared with #5 and NEO-III-14U. Furthermore, G925-s50 effectively inhibited NS3 protease activity in living cells and HCV replication in vitro. Overall, we have demonstrated rational RNA aptamer design based on features of both aptamer and target molecules, as well as successfully combining aptamer function and increasing NS3 inhibition.

Url:
DOI: 10.1093/jb/mvi042

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:70528AE6124F359D8D24EBE10DCB172BC828CCD1

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Rational Design of Dual-Functional Aptamers That Inhibit the Protease and Helicase Activities of HCV NS3</title>
<author>
<name sortKey="Umehara, Takuya" sort="Umehara, Takuya" uniqKey="Umehara T" first="Takuya" last="Umehara">Takuya Umehara</name>
</author>
<author>
<name sortKey="Fukuda, Kotaro" sort="Fukuda, Kotaro" uniqKey="Fukuda K" first="Kotaro" last="Fukuda">Kotaro Fukuda</name>
</author>
<author>
<name sortKey="Nishikawa, Fumiko" sort="Nishikawa, Fumiko" uniqKey="Nishikawa F" first="Fumiko" last="Nishikawa">Fumiko Nishikawa</name>
</author>
<author>
<name sortKey="Kohara, Michinori" sort="Kohara, Michinori" uniqKey="Kohara M" first="Michinori" last="Kohara">Michinori Kohara</name>
</author>
<author>
<name sortKey="Hasegawa, Tsunemi" sort="Hasegawa, Tsunemi" uniqKey="Hasegawa T" first="Tsunemi" last="Hasegawa">Tsunemi Hasegawa</name>
</author>
<author>
<name sortKey="Nishikawa, Satoshi" sort="Nishikawa, Satoshi" uniqKey="Nishikawa S" first="Satoshi" last="Nishikawa">Satoshi Nishikawa</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:70528AE6124F359D8D24EBE10DCB172BC828CCD1</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1093/jb/mvi042</idno>
<idno type="url">https://api.istex.fr/ark:/67375/HXZ-RBWR4510-W/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001536</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001536</idno>
<idno type="wicri:Area/Istex/Curation">001536</idno>
<idno type="wicri:Area/Istex/Checkpoint">000A78</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000A78</idno>
<idno type="wicri:doubleKey">0021-924X:2005:Umehara T:rational:design:of</idno>
<idno type="wicri:Area/Main/Merge">002F96</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Rational Design of Dual-Functional Aptamers That Inhibit the Protease and Helicase Activities of HCV NS3</title>
<author>
<name sortKey="Umehara, Takuya" sort="Umehara, Takuya" uniqKey="Umehara T" first="Takuya" last="Umehara">Takuya Umehara</name>
<affiliation></affiliation>
<affiliation>
<wicri:noCountry code="subField">and</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Fukuda, Kotaro" sort="Fukuda, Kotaro" uniqKey="Fukuda K" first="Kotaro" last="Fukuda">Kotaro Fukuda</name>
<affiliation></affiliation>
<affiliation>
<wicri:noCountry code="subField">and</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Nishikawa, Fumiko" sort="Nishikawa, Fumiko" uniqKey="Nishikawa F" first="Fumiko" last="Nishikawa">Fumiko Nishikawa</name>
<affiliation>
<wicri:noCountry code="subField">305-8566;</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Kohara, Michinori" sort="Kohara, Michinori" uniqKey="Kohara M" first="Michinori" last="Kohara">Michinori Kohara</name>
<affiliation>
<wicri:noCountry code="subField">113-8613</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Hasegawa, Tsunemi" sort="Hasegawa, Tsunemi" uniqKey="Hasegawa T" first="Tsunemi" last="Hasegawa">Tsunemi Hasegawa</name>
<affiliation>
<wicri:noCountry code="subField">and</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Nishikawa, Satoshi" sort="Nishikawa, Satoshi" uniqKey="Nishikawa S" first="Satoshi" last="Nishikawa">Satoshi Nishikawa</name>
<affiliation></affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Japon</country>
<wicri:regionArea>To whom correspondence should be addressed. Tel: +81-298-61-6085, Fax: +81-298-61-6159</wicri:regionArea>
<wicri:noRegion>Fax: +81-298-61-6159</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Journal of Biochemistry</title>
<title level="j" type="abbrev">J Biochem</title>
<idno type="ISSN">0021-924X</idno>
<imprint>
<publisher>Oxford University Press</publisher>
<date type="published">2005</date>
<biblScope unit="vol">137</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="339">339</biblScope>
<biblScope unit="page" to="347">347</biblScope>
</imprint>
<idno type="ISSN">0021-924X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0021-924X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The hepatitis C virus (HCV) non-structural protein 3 (NS3) is a multifunctional enzyme with protease and helicase activities. It is essential for HCV proliferation and is therefore a target for anti-HCV drugs. Previously, we obtained RNA aptamers that inhibit either the protease or helicase activity of NS3. During the present study, these aptamers were used to create advanced dual-functional (ADD) aptamers that were potentially more effective inhibitors of NS3 activity. The structural domain of the helicase aptamer, #5Δ, was conjugated via an oligo(U) tract to the 3′-end of the dual functional aptamer NEO-III-14U or the protease aptamer G9-II. The spacer length was optimized to obtain two ADD aptamers, NEO-35-s41 and G925-s50; both were more effective inhibitors of NS3 protease/helicase activity in vitro, especially the helicase, with a four- to five-fold increase in inhibition compared with #5 and NEO-III-14U. Furthermore, G925-s50 effectively inhibited NS3 protease activity in living cells and HCV replication in vitro. Overall, we have demonstrated rational RNA aptamer design based on features of both aptamer and target molecules, as well as successfully combining aptamer function and increasing NS3 inhibition.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F96 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 002F96 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     ISTEX:70528AE6124F359D8D24EBE10DCB172BC828CCD1
   |texte=   Rational Design of Dual-Functional Aptamers That Inhibit the Protease and Helicase Activities of HCV NS3
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021